<DOC>
	<DOCNO>NCT01092962</DOCNO>
	<brief_summary>Idiopathic nephrotic syndrome steroid-sensitive 90 % case child . However 60 % case steroid dependent require treatment immunosuppressive agent . Cyclophosphamide ciclosporin use long time reduce steroid dependency , duration treatment restrict gonadotoxicity cyclophosphamide nephrotoxicity ciclosporin . Mycophenolate mofetil appear alternative treatment without gonadotoxicity nephrotoxicity . However , contrary cyclophosphamide , mycophenolate mofetil seem residual action treatment must maintain month year . The aim study compare efficacy cyclophosphamide mycophenolate mofetil steroid dependent nephrotic syndrome child .</brief_summary>
	<brief_title>Cyclophosphamide Versus Mycophenolate Mofetil Treatment Steroid-dependent Nephrotic Syndrome Children</brief_title>
	<detailed_description>Aim study : Comparison efficacy cyclophosphamide 148mg/kg 12 week mycophenolate mofetil 1200mg/m² 18 month , child steroid dependent nephrotic syndrome . The 70 patient recruit 26 centre paediatric nephrology France , include randomized time relapse . They receive steroid treatment 2 arm . The primary point occurrence relapse 24 month follow-up . Detection relapse do use dipstick confirm biological dosage ( albuminemia proteinuria/CREATININURIA ratio ) . Clinical biological check do every 3 month study .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Nephrotic Syndrome</mesh_term>
	<mesh_term>Nephrosis</mesh_term>
	<mesh_term>Nephrosis , Lipoid</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>child 2 16 year old steroid dependency ≥30mg/m² eod steroid dependency ≥15mg/m² eod occurrence : least 2 relapse 1 year , adverse event steroid therapy ( height rate ≤1SD , obesity , complication ) severe complication nephrotic syndrome ( thrombosis , collapse , severe infection , … ) inform consent steroid resistant nephrotic syndrome prior treatment cyclophosphamide , mycophenolate mofetil cyclosporine absence contraception pubescent girl allergy cyclophosphamide mycophenolate mofetil malignant disease treatment immunosuppressant treatment nonsteroid antiinflammatory anti proteinuric medication ( enzyme converse antagonist angiotensin II receptor antagonist ) absence inform consent participation therapeutic trial</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Children</keyword>
	<keyword>Mycophenolate mofetil</keyword>
	<keyword>Cyclophosphamide</keyword>
	<keyword>Idiopathic nephrotic steroid sensitive syndrome</keyword>
</DOC>